Pentwater Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Pentwater Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-860,000	Closed	-$64.5M	–	172
2015 Q3	$64.5M	Buy	860,000 +680,000	+378%	+$50.8M	0.57%	34
2015 Q2	$13.6M	Sell	180,000 -95,000	-35%	-$5.09M	0.07%	86
2015 Q1	$13.8M	Sell	275,000 -225,000	-45%	-$9.44M	0.1%	79
2014 Q4	$17.3M	Sell	500,000 -119,400	-19%	-$4.17M	0.12%	70
2014 Q3	$20.3M	Buy	619,400 +8,710	+1%	+$307K	0.2%	74
2014 Q2	$23.4M	Buy	610,690 +220,690	+57%	+$7.7M	0.25%	48
2014 Q1	$15.5M	Buy	+390,000	New	+$17.4M	0.41%	38

Pentwater Capital Management's KYTH Position: Q4 2015 in Review

Pentwater Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 860,000 shares — an estimated $64.5M sold.

Pentwater Capital Management first reported a position in KYTH in Q1 2014 and held it in 7 quarters. The position peaked at $64.5M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Pentwater Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Pentwater Capital Management sold 860,000 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $64.5M.
Pentwater Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 7 quarters.
Pentwater Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $64.5M in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Pentwater Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.